-
, immunocompetent, patient‑derived multi‑organ models, using induced pluripotent stem cells (iPSCs) and organ‑on‑chip technologies, to better understand disease mechanisms and accelerate therapeutic discovery
-
, gut, and immune system. The MIMIC programme aims to develop human, immunocompetent, patient‑derived multi‑organ models, using induced pluripotent stem cells (iPSCs) and organ‑on‑chip technologies
-
cardiomyocytes go? How do they integrate with the host tissue? When do they begin contributing to heart function? At present, even imaging cells deep within therapy‑scale EHTs is impossible - let alone visualising
Searches related to chip
Enter an email to receive alerts for chip positions